Vor Biopharma VOR
NASDAQ VOR
$19.63 -0.46 (-2.30%)
As of: Nov 12, 2026 · 9:30 AM EST

Vor Biopharma (VOR) Return on Capital Employed [ROCE] (2021 - 2026)

Updated

Vor Biopharma (VOR) reported Return on Capital Employed [ROCE] of -39.22% for Q3 2026, up 174.19 percentage points from -213.41% a year earlier but down 7.87 percentage points from the prior quarter.

Analysis

Vor Biopharma (VOR) Return on Capital Employed [ROCE] (2021 - 2026) Analysis & Trends

For FY2025, Vor Biopharma posted Return on Capital Employed [ROCE] of -133.52%, down 53.74 percentage points from FY2024.

  • Return on Capital Employed [ROCE] has declined for three consecutive years, with a four-year change of -87.23 percentage points (FY2021 to FY2025).
  • By year, Return on Capital Employed [ROCE] came in at -79.78% in FY2024 (-25.73 pp), -54.05% in FY2023 (-17.82 pp), -36.23% in FY2022 (+10.06 pp) and -46.29% in FY2021.
  • Five-year quarterly Return on Capital Employed [ROCE] spans a low of -372.73% in Q2 2025 and a high of -28.70% in Q4 2021.
  • Year over year, Return on Capital Employed [ROCE] has now increased in each of the last three quarters, with an average year-over-year change of +7.00 percentage points over the last eight quarters.
  • The high point for year-over-year Return on Capital Employed [ROCE] in five years was Q2 2026 (a gain of 341.38 percentage points); the low point was Q2 2025 (a drop of 283.91 percentage points).
  • Per Business Quant data, the three quarters before Q3 2026 came in at -31.35% (Q2 2026), -79.58% (Q1 2026) and -125.98% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.52%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 21.60%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.65%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.91%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 17.37%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.15%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 11.32%
10 Vor Biopharma 1.20 Bn -692.85 Mn - -39.22%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -39.22%
Jun 30, 2026 -31.35%
Mar 31, 2026 -79.58%
Dec 31, 2025 -125.98%
Sep 30, 2025 -213.41%
Jun 30, 2025 -372.73%
Mar 31, 2025 -111.68%
Dec 31, 2024 -109.34%
Sep 30, 2024 -103.10%
Jun 30, 2024 -88.82%
Mar 31, 2024 -75.54%
Dec 31, 2023 -64.63%
Sep 30, 2023 -55.34%
Jun 30, 2023 -44.30%
Mar 31, 2023 -36.63%
Dec 31, 2022 -38.96%
Sep 30, 2022 -42.56%
Jun 30, 2022 -37.53%
Mar 31, 2022 -35.45%
Dec 31, 2021 -28.70%
API Access

Vor Biopharma Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=VOR&period=max&api_key=YOUR_API_KEY